January 2, 2009 — On December 31, 2008, Celgene, the manufacturer of tinzaparin sodium injection (Innohep) issued a Dear Healthcare Professional Letter in regard to an increased risk for death in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results